Literature DB >> 22059957

Vitamin d and metabolic syndrome risk factors: evidence and mechanisms.

Atif B Awad1, Lini Alappat, Michael Valerio.   

Abstract

The metabolic syndrome develops in an individual with any three of the following risk factors: obesity, diabetes, inflammation, hypertension, dyslipidemia, and thrombosis. Recent evidence suggests that vitamin D may play a role in the development of some of these risk factors. The metabolic syndrome is more common in western societies than the underdeveloped countries. Individuals in western societies usually consume a high calorie diet that lacks essential nutrients and, by virtue of being located in the northern hemisphere, they have limited sun exposures which restrict their vitamin D synthesis. Moreover, the lifestyle of these societies is considered sedentary. These dietary and environmental factors coupled with the sedentary lifestyle predispose them to metabolic syndrome risk factors. Active research revealed the role of vitamin D in the development of obesity, diabetes, inflammation, and hypertension. On the other hand, limited research has been done on the role of vitamin D in other risk factors such as dyslipidemia and thrombosis. The scientific community proposes to increase the current vitamin D fortification level in foods to reduce the risk factors of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22059957     DOI: 10.1080/10408391003785458

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  22 in total

1.  Preoperative Nutritional Deficiencies in Bariatric Surgery Candidates in Korea.

Authors:  Bo Chuan Tan; Young Suk Park; Yongjoon Won; Sangjun Lee; So Hyun Kang; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  Obes Surg       Date:  2021-03-08       Impact factor: 4.129

2.  Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies.

Authors:  Rong Ma; Yang Gu; Shuang Zhao; Jingxia Sun; Lynn J Groome; Yuping Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-07       Impact factor: 4.310

3.  Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells.

Authors:  Weijie Zhong; Baihan Gu; Yang Gu; Lynn J Groome; Jingxia Sun; Yuping Wang
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-05       Impact factor: 4.292

4.  Placental vitamin D receptor expression is decreased in human idiopathic fetal growth restriction.

Authors:  T P H Nguyen; H E J Yong; T Chollangi; A J Borg; S P Brennecke; P Murthi
Journal:  J Mol Med (Berl)       Date:  2015-02-27       Impact factor: 4.599

5.  Vitamin D Status Is Associated with Metabolic Syndrome in a Clinic-Based Sample of Hispanic Adults.

Authors:  Giselle M Diaz; Lilliana González; Grisel Ramos-Trautmann; Cynthia Marie Pérez; Cristina Palacios
Journal:  Metab Syndr Relat Disord       Date:  2016-01-07       Impact factor: 1.894

6.  Effect of 1-year oral cholecalciferol on a metabolic profile and blood pressure in poor-controlled type 2 diabetes mellitus: an open-label randomized controlled pilot study.

Authors:  M Barale; R Rossetto Giaccherino; E Ghigo; M Procopio
Journal:  J Endocrinol Invest       Date:  2020-08-17       Impact factor: 4.256

7.  Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis.

Authors:  Gwan Gyu Song; Sang-Cheol Bae; Young Ho Lee
Journal:  Clin Rheumatol       Date:  2012-09-02       Impact factor: 2.980

8.  Relationship between serum 25-hydroxyvitamin D and lower extremity arterial disease in type 2 diabetes mellitus patients and the analysis of the intervention of vitamin D.

Authors:  Wan Zhou; Shan-Dong Ye
Journal:  J Diabetes Res       Date:  2015-04-01       Impact factor: 4.011

9.  Prevalence of vitamin D deficiency and association with metabolic syndrome in a Qatari population.

Authors:  K Al-Dabhani; K K Tsilidis; N Murphy; H A Ward; P Elliott; E Riboli; M Gunter; I Tzoulaki
Journal:  Nutr Diabetes       Date:  2017-04-10       Impact factor: 5.097

10.  1,25(OH)2D3 Induces Placental Vascular Smooth Muscle Cell Relaxation by Phosphorylation of Myosin Phosphatase Target Subunit 1Ser507: Potential Beneficial Effects of Vitamin D on Placental Vasculature in Humans.

Authors:  Xiuyue Jia; Yang Gu; Lynn J Groome; Mahmoud Al-Kofahi; J Steven Alexander; Weimin Li; Yuping Wang
Journal:  Biol Reprod       Date:  2016-04-13       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.